[go: up one dir, main page]

AU1064800A - Products and methods - Google Patents

Products and methods

Info

Publication number
AU1064800A
AU1064800A AU10648/00A AU1064800A AU1064800A AU 1064800 A AU1064800 A AU 1064800A AU 10648/00 A AU10648/00 A AU 10648/00A AU 1064800 A AU1064800 A AU 1064800A AU 1064800 A AU1064800 A AU 1064800A
Authority
AU
Australia
Prior art keywords
products
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10648/00A
Inventor
Edward Richard Bacon
Evan Gustow
Gregory Lynn Mcintire
Robert Allen Snow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
Nycomed Amersham PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Amersham PLC filed Critical Nycomed Amersham PLC
Publication of AU1064800A publication Critical patent/AU1064800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • A61K51/1251—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles micro- or nanospheres, micro- or nanobeads, micro- or nanocapsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU10648/00A 1998-11-12 1999-11-12 Products and methods Abandoned AU1064800A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10812198P 1998-11-12 1998-11-12
US60108121 1998-11-12
GB9900824 1999-01-14
GB9900824 1999-01-14
PCT/GB1999/003774 WO2000029034A1 (en) 1998-11-12 1999-11-12 Products and methods

Publications (1)

Publication Number Publication Date
AU1064800A true AU1064800A (en) 2000-06-05

Family

ID=26314986

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10648/00A Abandoned AU1064800A (en) 1998-11-12 1999-11-12 Products and methods

Country Status (2)

Country Link
AU (1) AU1064800A (en)
WO (1) WO2000029034A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5218500A (en) * 1999-06-22 2001-01-09 Aventis Research & Technologies Gmbh & Co. Kg Stable, radioactively marked nanoparticles, method for the production and utilization thereof
US6547816B1 (en) 1999-07-12 2003-04-15 Civatech Corporation Formable integral source material for medical devices
AU2000259288A1 (en) * 2000-02-18 2001-08-27 Civatech Corporation Formable integral source material for medical and industrial devices
CA2555435C (en) * 2004-02-20 2011-07-12 Algeta As Alpha-emitting hydroxyapatite particles
US7686756B2 (en) 2006-08-29 2010-03-30 Ciratech Oncology Brachytherapy devices and related methods and computer program products
US9849200B2 (en) 2010-09-16 2017-12-26 Mo-Sci Corporation Strontium phosphate microparticle for radiological imaging and therapy
US8865123B1 (en) 2010-09-16 2014-10-21 Mo-Sci Corporation Strontium phosphate microparticle for radiological imaging and therapy
US20130253255A1 (en) * 2010-11-18 2013-09-26 Northern Oncology (Pty) Ltd Brachytherapy Seed, Methodology and Calculating Dose of Brachytherapy and Method of Treatment
GB2521997A (en) 2013-09-06 2015-07-15 Biocompatibles Uk Ltd Radiopaque polymers
JP6608925B2 (en) * 2014-10-21 2019-11-20 エムオー−エスシーアイ コーポレイション Strontium phosphate for medical imaging and medical therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663685A (en) * 1968-04-01 1972-05-16 Minnesota Mining & Mfg Biodegradable radioactive particles
US4505888A (en) * 1983-05-27 1985-03-19 E. I. Du Pont De Nemours & Company Tracer for circulation determinations
DE4315002C1 (en) * 1993-05-06 1994-08-18 Kernforschungsz Karlsruhe Vascular implant
WO1997001304A1 (en) * 1995-06-29 1997-01-16 Mallinckrodt Medical, Inc. Radiolabeled apatite particles containing a paramagnetic ion
US6589502B1 (en) * 1995-11-27 2003-07-08 International Brachytherapy S.A. Radioisotope dispersed in a matrix for brachytherapy
FR2772746B1 (en) * 1997-12-23 2000-01-28 Commissariat Energie Atomique PROCESS FOR THE MANUFACTURE OF AN APATITIC CERAMIC, PARTICULARLY FOR BIOLOGICAL USE
JP2002503530A (en) * 1998-02-19 2002-02-05 ラディアンス・メディカル・システムズ・インコーポレイテッド Thin film irradiation source

Also Published As

Publication number Publication date
WO2000029034A1 (en) 2000-05-25

Similar Documents

Publication Publication Date Title
AU6503299A (en) High-beta-conglycinin products and their use
AU1705500A (en) Product detector and method therefor
AU9790198A (en) Compounds and methods
AU4208799A (en) Interleukins-21 and 22
AU6111699A (en) Novel method and compounds
AUPP466598A0 (en) Product and process
AU2349399A (en) R-lansoprazole compositions and methods
AU1064800A (en) Products and methods
AU3198299A (en) Multi-carotenoid product
AU1083501A (en) Antibiotic-metal complex and methods
AU3936699A (en) Novel vinca-alkaloid derivatives and preparation method
AU6819598A (en) Anti-counterfeit method and product using the method
AUPO425996A0 (en) Laminating methods and products
AU2980799A (en) Lectomedin materials and methods
AU7764798A (en) Product and method for providing glutamine
AU2231899A (en) Pudding preparation and products
AU7023300A (en) Product and method
AU1330301A (en) Canelo products and methods of making and using same
AU698312B3 (en) Document protection methods and products
AU6750498A (en) Hexahydroaspartame amides and method for the preparation thereof
AUPQ165199A0 (en) Product and process
AUPP261198A0 (en) Method and device
AU3148299A (en) Imidazol-like products and derivatives
AU1834800A (en) Cyanophosphonamides and method for preparation
GB9826121D0 (en) Products and methods

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase